- Q1 2024 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024$1.09 (-9.17%)Earnings
- Q4 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 21, 2024$1.31 (+28.43%)Earnings
- Q3 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023$0.79 (+6.68%)Earnings
- X4 Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- X4 Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2023$1.05 (-35.98%)Earnings
- X4 Pharmaceuticals Inc 4WHIM Phase 3 Clinical Trial Update Call TranscriptMay 16, 2023
- Q1 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023$1.54 (+4.05%)Earnings
- Q4 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 21, 2023$0.8954 (+0.97%)Earnings
- X4 Pharmaceuticals Inc To Discuss Key Top-Line 4WHIM Trial Results TranscriptNov 29, 2022
- X4 Pharmaceuticals Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2022$1.89 (-3.57%)Earnings
- X4 Pharmaceuticals Inc at Canaccord Genuity Growth Conference TranscriptAug 11, 2022
- Q2 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$1.27 (-1.55%)Earnings
- Q1 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2022$1.04 (-0.95%)Earnings
- X4 Pharmaceuticals Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) TranscriptApr 14, 2022
- X4 Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Q4 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 17, 2022$1.77 (-10.61%)Earnings
- X4 Pharmaceuticals Inc at B Riley Oncology Conference (Virtual) TranscriptJan 28, 2022
- Q3 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2021$5.15 (-8.04%)Earnings
- X4 Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021$5.66 (-4.55%)Earnings
- Q1 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2021$8.12 (+1.50%)Earnings
- Q4 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 04, 2021$9.18 (-5.75%)Earnings
- X4 Pharmaceuticals Inc Dr. Ragan Discusses X4's Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases TranscriptDec 23, 2020
- Q3 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$6.01 (-6.68%)Earnings
- Q2 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2020$7.73 (-3.50%)Earnings
- X4 Pharmaceuticals Inc Post-EHA Corporate Update TranscriptJun 12, 2020
- Q1 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$8.56 (-4.89%)Earnings
- X4 Pharmaceuticals Inc Virtual Analyst Day - A Deep Dive into WHIM Syndrome TranscriptApr 07, 2020
- Q4 2019 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 12, 2020$8.13 (-5.24%)Earnings
- Q3 2019 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019$13.41 (+3.79%)Earnings
X4 Pharmaceuticals Inc at Stifel Healthcare Conference Transcript
I'm Stephen Willey, one of the senior biotech analysts here at Stifel. Glad to have with us for the next session Paula Ragan who is the Chief Executive Officer of X4 and the Chief Financial Officer, Adam Mostafa, is also in attendance as well. We're just going to have kind of an informal chat. If anyone has a question at any point, feel free to raise your hand. We'll try to get you acknowledged and get your questions asked and answered. Paula, not sure if you want to make any kind of opening comments before we get into Q&A.
Sure. We're -- so thank you for hosting. Thanks to the Stifel team for this conference. It's nice to be in person with everyone. And I think we're really excited about where the company is at. We're on the cusp of Phase 3 data. We just had a great readout in September and a broader indication. And certainly coming off the crazy biotech markets of 2022, we're in a really nice position for a successful 2023 and beyond. So great to be here
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)